Erratum to "Transforming growth factor-β1 enhanced vascular endothelial growth factor synthesis in mesenchymal stem cells" [Biochem. Biophys. Res. Commun. 365 (2008) 548-554] (DOI:10.1016/j.bbrc.2007.11.014);Transforming growth factor-β1 enhanced vascular endothelial growth factor synthesis in mesenchymal stem cells

Biochemical and Biophysical Research Communications

Volumn 365, Issue 3, 2008, Pages 548-554

  Wang, Xiao Jun ^a   Dong, Zhan ^a   Zhong, Xiao Hua ^a   Shi, Rui Zhen ^a   Huang, Song Hua ^a   Lou, Yue ^a   Li, Qing Ping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Extracellular signal regulated kinase; Mesenchymal stem cells; Transforming growth factor 1; Vascular endothelial growth factor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; ENZYME SYNTHESIS; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

EID: 36549088025     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.104     Document Type: Erratum

References (39)

1. Caplan A.I., and Dennis J.E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98 (2006) 1076-1084
2. Wang Y., Haider H.K., Ahmad N., Xu M., Ge R., and Ashraf M. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J. Mol. Cell. Cardiol. 40 (2006) 736-745
3. Uemura R., Xu M.F., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98 (2006) 1414-1421
4. Zhou B., Han Z., Poon M., and Pu W. Mesenchymal stem/stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: Enhancement of cell recruitment and entrapment. Med. Hypoth. 68 (2007) 1268-1271
5. Barthomeuf C., Lamy S., Blanchette M., Boivin D., Gingras D., and Béliveau R. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis. Free Radic. Bio. Med. 40 (2006) 581-590
6. Pepper M.S. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8 (1997) 21-43
7. Mallat Z., and Tedgui A. The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives. Curr. Opin. Lipidol. 13 (2002) 523-529
8. Redondo S., Santos-Gallego C.G., Ganado P., Garcia M., Rico L., Del Rio M., and Tejerina T. Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-β. Circulation 107 (2003) 626-629
9. Redondo S., Ruiz E., Santos-Gallego C.G., Padilla E., and Tejerina T. Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-{gamma}, transforming growth factor-{beta}1, and a Smad2-dependent mechanism. Diabetes 54 (2005) 811-817
10. Kamaraju A.K., and Roberts A.B. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J. Biol. Chem. 280 (2005) 1024-1036
11. Qureshi H.Y., Ahmad R., Sylvester J., and Zafarullah M. Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-β in human chondrocytes. Cell. Signal. 19 (2007) 1643-1651
12. Isele N.B., Lee H.S., Landshamer S., Straube A., Padovan C.S., Plesnila N., and Culmsee C. Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons. Neurochem. Int. 50 (2007) 243-250
13. Kanda Y., and Watanabe Y. Nicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cells. Life Sci. 80 (2007) 1409-1414
14. Wang X.J., and Li Q.P. The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases. Biochem. Biophys. Res. Commun. 359 (2007) 189-193
15. Nygren J.M., Jovinge S., Breitbach M., Sawen P., Roll W., Hescheler J., Taneera J., Fleischmann B.K., and W Jacobsen S.E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10 (2004) 494-501
16. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., Pell C.L., Johnstone B.H., Considine R.V., and March K.L. Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells. Circulation 109 (2004) 1292-1298
17. Lee H.J., Kim K.S., Park I.H., and Kim S.U. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS. ONE 2 (2007) 156
18. Jung J.E., Lee H.G., Cho I.H., Chung D.H., Yoon S.H., Yang Y.M., Lee J.W., Choi S., Park J.W., Ye S.K., and Chung M.H. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 19 (2005) 1296-1298
19. Wang M., Zhang W., Crisostomo P., Markel T., Meldrum K.K., Fu X.Y., and Meldrum D.R. STAT3 mediates bone marrow mesenchymal stem cell VEGF production. J. Mol. Cell. Cardiol. 42 (2007) 1009-1015
20. Park H.J., Kim M.N., Kim J.G., Bae Y.H., Bae M.K., Wee H.J., Kim T.W., Kim B.S., Kim J.B., Bae S.K., et al. Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat. BBA-Mol. Cell. Res. 1773 (2007) 1462-1472
21. Dai Y., Xu M., Wang Y., Pasha Z., Li T., and Ashraf M. HIF-1α induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J. Mol. Cell. Cardiol. 42 (2007) 1036-1044
22. Yang S.H., Lin J.K., Huang C.J., Chen W.S., Li S.Y., and Chiu J.H. Silibinin Inhibits Angiogenesis via Flt-1, but not KDR, Receptor Up-Regulation1. J. Surg. Res. 128 (2005) 140-146
23. Zhou H.J., Wang W.Q., Wu G.D., Lee J., and Li A. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vasc. Pharmacol. 47 (2007) 131-138
24. Ayalasomayajula S.P., and Kompella U.B. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. Eur. J. Pharmacol. 458 (2003) 283-289
25. Xiao Z., Wang Y., Lu L., Li Z., Peng Z., Han Z., and Hao Y. Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro. Leuk. Res. 30 (2006) 54-59
26. Nakagawa T., Lan H.Y., Zhu H.J., Kang D.H., Schreiner G.F., and Johnson R.J. Differential regulation of VEGF by TGF-β and hypoxia in rat proximal tubular cells. Am. J. Physiol. Renal Physiol. 287 (2004) 658-664
27. Mallet C., Vittet D., Feige J.J., and Bailly S. TGFβ1 Induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 24 (2006) 2420-2427
28. Tokuda H., Hatakeyama D., Akamatsu S., Tanabe K., Yoshida M., Shibata T., and Kozawa O. Involvement of MAP kinases in TGF-β-stimulated vascular endothelial growth factor synthesis in osteoblasts. Arch. Biochem. Biophys. 415 (2003) 117-125
29. Liang Z., Brooks J., Willard M., Liang K., Yoon Y., Kang S., and Shim H. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem. Biophys. Res. Commun. 359 (2007) 716-722
30. Takai S., Tokuda H., Hanai Y., and Kozawa O. Activation of phosphatidylinositol 3-kinase/Akt limits FGF-2-induced VEGF release in osteoblasts. Mol. Cell. Endocrinol. 267 (2007) 46-54
31. Fang J., Ding M., Yang L., Liu L.Z., and Jiang B.H. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell. Signal. 19 (2007) 2487-2497
32. Lien S.C., Usami S., Chien S., and Chiu J.J. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-β1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells. Cell. Signal. 18 (2006) 1270-1278
33. Martínez-Salgado C., Fuentes-Calvo I., García-Cenador B., Santos E., and López-Novoa J.M. Involvement of H- and N-Ras isoforms in transforming growth factor-β1-induced proliferation and in collagen and fibronectin synthesis. Exp. Cell. Res. 312 (2006) 2093-2106
34. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 (2001) 153-183
35. Liu J., Schuff-Werner P., and Steiner M. Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells. Biochem. Biophys. Res. Commun. 343 (2006) 183-189
36. Slomiany M.G., Black L.A., Kibbey M.M., Day T.A., and Rosenzweig S.A. IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. Biochem. Biophys. Res. Commun. 342 (2006) 851-858
37. Tian Y.C., Chen Y.C., Chang C.T., Hung C.C., Wu M.S., Phillips A., and Yang C.W. Epidermal growth factor and transforming growth factor-β1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Exp. Cell. Res. 313 (2007) 2367-2377
38. Zhou X., Hu H., Huynh M.L.N., Kotaru C., Balzar S., Trudeau J.B., and Wenzel S.E. Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF-β1-stimulated primary human fibroblasts. J. Allergy. Clin. Immun. 119 (2007) 1388-1397
39. Angelo L.S., and Kurzrock R. Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin. Cancer Res. 13 10 (2007) 2825-2830